BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31582381)

  • 1. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
    Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
    Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DHODH modulates transcriptional elongation in the neural crest and melanoma.
    White RM; Cech J; Ratanasirintrawoot S; Lin CY; Rahl PB; Burke CJ; Langdon E; Tomlinson ML; Mosher J; Kaufman C; Chen F; Long HK; Kramer M; Datta S; Neuberg D; Granter S; Young RA; Morrison S; Wheeler GN; Zon LI
    Nature; 2011 Mar; 471(7339):518-22. PubMed ID: 21430780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs. regression in vivo.
    Lister JA; Capper A; Zeng Z; Mathers ME; Richardson J; Paranthaman K; Jackson IJ; Elizabeth Patton E
    J Invest Dermatol; 2014 Jan; 134(1):133-140. PubMed ID: 23831555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.
    Bonet C; Luciani F; Ottavi JF; Leclerc J; Jouenne FM; Boncompagni M; Bille K; Hofman V; Bossis G; Marco de Donatis G; Strub T; Cheli Y; Ohanna M; Luciano F; Marchetti S; Rocchi S; Birling MC; Avril MF; Poulalhon N; Luc T; Hofman P; Lacour JP; Davidson I; Bressac-de Paillerets B; Ballotti R; Marine JC; Bertolotto C
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.
    Fernández-Barral A; Orgaz JL; Baquero P; Ali Z; Moreno A; Tiana M; Gómez V; Riveiro-Falkenbach E; Cañadas C; Zazo S; Bertolotto C; Davidson I; Rodríguez-Peralto JL; Palmero I; Rojo F; Jensen LD; del Peso L; Jiménez B
    Neoplasia; 2014 Jun; 16(6):529-42. PubMed ID: 25030625
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Ennen M; Keime C; Gambi G; Kieny A; Coassolo S; Thibault-Carpentier C; Margerin-Schaller F; Davidson G; Vagne C; Lipsker D; Davidson I
    Clin Cancer Res; 2017 Nov; 23(22):7097-7107. PubMed ID: 28855355
    [No Abstract]   [Full Text] [Related]  

  • 7. In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
    Guo X; Xu Y; Zhao Z
    Mol Cancer; 2015 Mar; 14():60. PubMed ID: 25890285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TYRP1 mRNA level is stable and MITF-M-independent in drug-naïve, vemurafenib- and trametinib-resistant BRAF
    Hartman ML; Czyz M
    Arch Dermatol Res; 2020 Jul; 312(5):385-392. PubMed ID: 31624899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
    Kundu A; Quirit JG; Khouri MG; Firestone GL
    Mol Carcinog; 2017 Jan; 56(1):49-61. PubMed ID: 26878440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma Regression and Recurrence in Zebrafish.
    Wojciechowska S; Zeng Z; Lister JA; Ceol CJ; Patton EE
    Methods Mol Biol; 2016; 1451():143-53. PubMed ID: 27464806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF.
    Seberg HE; Van Otterloo E; Loftus SK; Liu H; Bonde G; Sompallae R; Gildea DE; Santana JF; Manak JR; Pavan WJ; Williams T; Cornell RA
    PLoS Genet; 2017 Mar; 13(3):e1006636. PubMed ID: 28249010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous suppression of MITF and BRAF V600E enhanced inhibition of melanoma cell proliferation.
    Kido K; Sumimoto H; Asada S; Okada SM; Yaguchi T; Kawamura N; Miyagishi M; Saida T; Kawakami Y
    Cancer Sci; 2009 Oct; 100(10):1863-9. PubMed ID: 19659611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.
    Falletta P; Sanchez-Del-Campo L; Chauhan J; Effern M; Kenyon A; Kershaw CJ; Siddaway R; Lisle R; Freter R; Daniels MJ; Lu X; Tüting T; Middleton M; Buffa FM; Willis AE; Pavitt G; Ronai ZA; Sauka-Spengler T; Hölzel M; Goding CR
    Genes Dev; 2017 Jan; 31(1):18-33. PubMed ID: 28096186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human skin neural crest progenitor cells are susceptible to BRAF(V600E)-induced transformation.
    Kumar SM; Dai J; Li S; Yang R; Yu H; Nathanson KL; Liu S; Zhou H; Guo J; Xu X
    Oncogene; 2014 Feb; 33(7):832-41. PubMed ID: 23334329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors.
    Liguoro D; Frigerio R; Ortolano A; Sacconi A; Acunzo M; Romano G; Nigita G; Bellei B; Madonna G; Capone M; Ascierto PA; Mancini R; Ciliberto G; Fattore L
    Cell Death Dis; 2024 Mar; 15(3):208. PubMed ID: 38472212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.
    Haq R; Yokoyama S; Hawryluk EB; Jönsson GB; Frederick DT; McHenry K; Porter D; Tran TN; Love KT; Langer R; Anderson DG; Garraway LA; Duncan LM; Morton DL; Hoon DS; Wargo JA; Song JS; Fisher DE
    Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4321-6. PubMed ID: 23447565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIT Suppresses BRAF
    Neiswender JV; Kortum RL; Bourque C; Kasheta M; Zon LI; Morrison DK; Ceol CJ
    Cancer Res; 2017 Nov; 77(21):5820-5830. PubMed ID: 28947418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of zebrafish melanocyte development by ligand-dependent BMP signaling.
    Gramann AK; Venkatesan AM; Guerin M; Ceol CJ
    Elife; 2019 Dec; 8():. PubMed ID: 31868592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.
    Wellbrock C; Marais R
    J Cell Biol; 2005 Aug; 170(5):703-8. PubMed ID: 16129781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MITF deficiency and oncogenic GNAQ each promote proliferation programs in zebrafish melanocyte lineage cells.
    Phelps GB; Amsterdam A; Hagen HR; García NZ; Lees JA
    Pigment Cell Melanoma Res; 2022 Sep; 35(5):539-547. PubMed ID: 35869673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.